Levofloxacin丨CAS 100986-85-4

Levofloxacin丨CAS 100986-85-4
Product Introduction:
Catalog No.: SS070480
CAS No.: 100986-85-4
Grade: USP43
Product Name: Levofloxacin
Molecular Formula: C18H20FN3O4
Molecular Weight: 361.37
Synonym(s): L-Ofloxacin
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of levofloxacin丨cas 100986-85-4 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Grade: USP43
Appearance: Light yellowish-White to Yellow-White crystals or crystalline Powder
Assay (on the anhydrous basis): 98.0%~102.0% of C18H20FN3O4
Identification: (1) IR (2) HPLC
Water: 2.0%~3.0%
Optical rotation: -92~-106°
Residue on ignition: 0.2% max
Procedure 1 (by HPLC)
N-Desmethyl levofloxacin: 0.3% max
Diamine derivative: 0.3% max
Levofloxacin N-oxide: 0.3% max
9-Desfluoro levofloxacin: 0.3% max
D-Isomer: 0.8% max
Any unknown impurity: 0.1% max
Total impurity (excluding D-Isomer): 0.5% max
Procedure 2 (by HPLC)
Levofloxacin related compound A (N-Desmethyl levofloxacin): 0.2% max
Levofloxacin related compound B: 0.13% max
Any other impurity: 0.10% max
Total impurities: 0.5% max
Residual solvents
Chloroform: 60 ppm max
Ethanol: 1000 ppm max
DMSO: 1000 ppm max

 

Transport Information

 

Parameter

Specification

UN Number

 

Class

 

Packing Group

 

H.S. Code

2941909099999

Stability & Reactivity

The product is chemically stable under standard ambient conditions.

Storage

Tightly closed. Store in a closed, dry, ventilated place

Condition to Avoid

Strong oxidizing agents

Package

 

 

Manufacturing Information

 

Parameter

Specification

Capacity

10MT/month

Frequency

 

Main Export Countries

 

Capacity/Batch

 

Experience

Production since 2007

Stock

 

 

 

 

Applications

 

1. Respiratory Tract Infections

Levofloxacin is a first-line treatment for:

Community-acquired pneumonia (CAP)

Acute bacterial sinusitis

Acute exacerbation of chronic bronchitis

Its excellent tissue penetration and long half-life make it particularly effective in treating deep respiratory infections.

2. Urinary Tract Infections (UTIs)

Used for both complicated and uncomplicated UTIs, including pyelonephritis.

Also effective for prostatitis caused by susceptible bacterial strains.

3. Skin and Soft Tissue Infections

Treats infections like cellulitis, abscesses, and infected wounds.

4. Gastrointestinal and Intra-abdominal Infections

Sometimes used in combination therapies to treat bacterial gastroenteritis and intra-abdominal sepsis.

5. Ophthalmic Use

Available as eye drops for treating bacterial conjunctivitis, keratitis, and other ocular infections.

6. Ear, Nose, and Throat (ENT) Infections

Effective in treating otitis media, pharyngitis, and tonsillitis in select cases.

7. Tuberculosis (MDR-TB and XDR-TB)

Used as a second-line drug in multi-drug resistant tuberculosis regimens.

8. Anthrax (Post-Exposure Prophylaxis)

Approved for inhalation anthrax exposure due to its activity against Bacillus anthracis.

 

Benefits

 

1. Broad-Spectrum Antibacterial Activity

Covers a wide range of pathogens, including:

Gram-negative bacteria: E. coli, Klebsiella, Pseudomonas aeruginosa

Gram-positive bacteria: Streptococcus pneumoniae, Staphylococcus aureus

Atypical organisms: Mycoplasma, Chlamydia, Legionella

2. Excellent Bioavailability

Almost 100% oral bioavailability - oral and IV doses are typically interchangeable, improving outpatient treatment options.

3. Long Half-Life

Allows once-daily dosing, improving patient compliance.

4. High Tissue Penetration

Penetrates well into lungs, sinuses, kidneys, prostate, and soft tissues, making it highly effective for deep-seated infections.

5. Well-Studied and Approved Globally

FDA-approved and widely prescribed in both hospital and outpatient settings.

 

Conclusion

 

Levofloxacin (CAS 100986-85-4) remains a powerful and versatile antibiotic, valued for its broad-spectrum coverage, high bioavailability, and convenient dosing schedule. When used responsibly, it plays a critical role in the management of serious infections in both inpatient and outpatient care. However, attention must be given to antibiotic stewardship and monitoring for side effects, especially in vulnerable populations.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us